When it comes to remaining ageless, celebrities are giving this trendy treatment a shot. Additionally, many celebrities have praised Xeomin, which received FDA approval in 2010, for reducing their ...
Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, today announced that the first patients have been enrolled in two global Phase III clinical trials — MINT-E (NCT07018700 ...
“It is our hope that the availability of multiple vial options for Xeomin ® (incobotulinumtoxinA) may minimize dosing waste and reduce patient out-of-pocket costs,“ said Glenn Block, Vice President ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback